Lv5
850 积分 2022-06-02 加入
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
5小时前
已完结
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
11天前
已完结
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
12天前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
14天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
14天前
已完结
Statistical methods for handling missing data to align with treatment policy strategy
20天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
肿瘤免疫治疗疗效评价标准——iRECIST解读
1个月前
已完结
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
2个月前
已关闭
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
2个月前
已关闭
皖公网安备34019202002308
